Peptide Atlas · Small molecule

Acetyl-L-Carnitine (ALCAR)

A meta-analysis of double-blind, placebo-controlled trials lasting 3 to 12 months in mild cognitive impairment and mild Alzheimer's disease found a small advantage for acetyl-L-carnitine over placebo on clinical and psychometric measures.

emerging

provisional
PubChem 7045767
2 citations
0 discussions
0 followers
ALC
ALCAR
O-acetyl-L-carnitine
acetylcarnitine
levacecarnine

Follow this molecule Ask the Hunter-Gatherer

What the evidence says

six tiers, never blended

emerging — human data exists, and it is thin or contested

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

No protocol has enough distinct humans behind it to be a protocol. One person saying it twice is still one person.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.